Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Floorless Preferred Stock/Debenture -- Ignore unavailable to you. Want to Upgrade?

To: Timelord who wrote (613)	7/10/1999 3:59:00 PM
From: RockyBalboa	Respond to of 1438

Important addentum, found in the filings: The conversion of our series B convertible preferred stock could also have consequences that could cause Nasdaq to delist our common stock. If the conversion and sale of our series B convertible preferred stock result in a decline in our common stock price, as discussed in the prior risk factor, the minimum bid price for our common stock could fall below $1.00. Nasdaq could also delist our common stock if it deems it necessary to protect investors and the public interest. If Nasdaq were to determine that the returns on our series B convertible preferred stock are excessive compared with the returns received by the holders of our common stock, and those excess returns were egregious, Nasdaq could delist our common stock. edgar-online.com

To: Timelord who wrote (613)	10/29/1999 3:56:00 AM
From: RockyBalboa	Respond to of 1438

Endings: finance.yahoo.com biz.yahoo.com CRANBURY, N.J.--(BUSINESS WIRE)--Oct. 14, 1999--Enamelon, Inc. (Nasdaq: ENML - news), which is using its roprietary ''remineralization'' technology to develop over-the-counter oral care products to rebuild and renew tooth enamel to help stop cavities before they begin, today announced that its common stock has been delisted from the National Market System effective with the close of business on October 14, 1999.